Related Experiment Video
Updated: Mar 10, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Stroke Risk Predictor Scoring Systems in Atrial Fibrillation
Tze-Fan Chao M D And1, Shih-Ann Chen M D1
1Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.
Insights
Identifying high-risk atrial fibrillation patients for stroke prevention is crucial. Current scoring systems like CHA2DS2-VASc help identify low-risk individuals who may not need oral anticoagulants.
Area of Science:
- Cardiology and Neurology
- Thrombosis and Anticoagulation
Background:
- Stroke prevention in atrial fibrillation (SPAF) requires accurate risk stratification to guide oral anticoagulant (OAC) therapy.
- Existing scoring systems (CHADS2, CHA2DS2-VASc, R2CHADS2, ATRIA) utilize various clinical factors to estimate stroke risk.
Approach:
- Review of current OACs, including novel oral anticoagulants (NOACs), and their safety/efficacy compared to warfarin.
- Evaluation of the evolving role of risk scores in the NOAC era, focusing on identifying patients unlikely to benefit from anticoagulation.
Key Points:
- The CHA2DS2-VASc score effectively identifies patients at truly low risk for thromboembolic events, who may not require OACs.
- Emerging scoring systems, R2CHADS2 and ATRIA, warrant further investigation for their potential to improve stroke prediction accuracy in AF.
Conclusions:
- Accurate risk stratification is essential for optimizing stroke prevention in atrial fibrillation patients.
- Further research is needed to validate newer scoring systems for enhanced stroke risk prediction in the context of NOACs.
Abstract:
An effective risk stratification which could help us identify high-risk patients who should take oral anticoagulants (OACs) is the key step for stroke prevention in atrial fibrillation (SPAF). Several scoring systems were available to estimate the risk of stroke in AF, including CHADS2, CHA2DS2-VASc, R2CHADS2 and ATRIA scores, which were constituted of different clinical risk factors. Recently, several new OACs (NOACs) were demonstrated to be at least as effective as warfarin in stroke prevention and were much safer regarding the risk of intra-cranial hemorrhage. In the era of NOACs, the roles of scoring schemes have shifted to identify patients with a truly low-risk of thromboembolic events, in whom OACs were not recommended. The CHA2DS2-VASc score is powerful in selecting "truly low-risk" patients who do not require anticoagulation. Whether the new-emerging scoring systems, R2CHADS2 and ATRIA scores, could further improve the stroke prediction in AF deserves a further study. ("SPAF", the same as the initials of a series of studies about aspirin, warfarin and stroke prevention in AF, was used as the abbreviation for "stroke prevention in atrial fibrillation" in this review article.).
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:25Assessment of apical radial pulse
The A-R pulse assessment involves simultaneous evaluation of the apical and radial pulses. When the apical and radial pulse rates vary, this assessment helps identify a pulse deficit.
Pre-Procedural Preparation
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:23Assessment of blood pressure in brachial artery(two-step method)
01:10Pre-Procedural Guidelines for Assessing Blood Pressure